Abstract
Neuroblastoma is the commonest malignancy in infancy and the commonest extra-cranial malignant tumour in children. From the time of diagnosis, management is by agreed protocols drawn up by large oncology groups. Using improved diagnostic methods and with greater understanding of tumour biology, tumour staging is more accurate, and different risk groups have been identified. Treatment is then more refined, such that those with less aggressive tumours receive less toxic treatment. The mainstays of treatment include surgery, chemotherapy and radiotherapy. More recently, biological agents have become available with improvement in survival. Overall, about 75% of children with neuroblastoma will survive long term. For those with biologically unfavourable tumours, fewer than 50% will survive, and intensifying current treatment modalities has made little difference. It seems likely that further improvement in outlook awaits the development of new biological agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Beckwith JB, Perrin EV (1963) In situ neuroblastomas: a contribution to the natural history of neural crest tumours. Am J Pathol 43(6):1089–1104
Blacklock JWS (1934) Neurogenic tumours of the sympathetic system in children. J Pathol Bacteriol 39:27–48
Brodeur GM (2018) Spontaneous regression of neuroblastoma. Cell Tissue Res 372(2):277–286
Cheung N-KV, Dyer MA (2018) Neuroblastoma: developmental biology, cancer genomics, and immunotherapy. Nat Rev Cancer 13(6):397–411
Cohn SL, Pearson ADJ, London WB et al (2009) The international neuroblastoma risk group (INRG) classification system: an INRG task force report. J Clin Oncol 27(2):289–297
Evans AE, D’Angio GJ, Randolph J (1971) A proposed staging system for children with neuroblastoma. Children’s cancer study Group A. Cancer 27:374–378
Farber S (1940) Neuroblastoma. Am J Dis Child 60:749–750
Fortner J, Nicastri A, Murphy ML (1968) Neuroblastoma: natural history and results of treating 133 cases. Ann Surg 167:132–142
James DH, Hustu O, Wrenn EL et al (1965) Combination chemotherapy in childhood neuroblastoma. JAMA 194:123–126
Johnsen JI, Dyberg C, Wickström M (2019) Neuroblastoma-a neural crest derived embryonal malignancy. Front Mol Neurosci 29(12):9
Kastriti ME, Kameneva P, Kamenev D et al (2019) Schwann cell precursors generate the majority of chromaffin cells in Zuckerkandl organ and some sympathetic neurons in paraganglia. Front Mol Neurosci 12:6–34
Kiely E (2005) A technique for excision of abdominal and pelvic neuroblastomas. Ann Roy Coll Surg Engl 89:342–348
Lehman EP (1932) Adrenal neuroblastoma in infancy – 15 year survival. Ann Surg 95:473
Monclair T, Brodeur GM, Ambros PF et al (2009) The international neuroblastoma risk group (INRG) staging system: an INRG task force report. J Clin Oncol 27(2):298–303
Newman EA, Abdessalam S, Aldrink JH et al (2019) Update on neuroblastoma. J Pediatr Surg 54(3):383–389
Phillips R (1953) Neuroblastoma. Ann R Coll Surg Engl 12:29–47
Ryan AL, Akinkuotu A, Pierro A et al (2020) The role of surgery in high-risk neuroblastoma. J Pediatr Hematol Oncol 42(1):1–7
Tsubota S, Kadomatsu K (2018). Origin and initiation Mechanisms of neuroblastoma. Cell Tissue Res 372:211–221
Virchow R (1864) Die Krankenhaften Geschwulste, vol 11. Hirschwald, Berlin, p 149
Wright JH (1910) Neurocytoma or neuroblastoma, a kind of tumour not generally recognised. J Exp Med 12:556–561
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kiely, E. (2023). Neuroblastoma. In: Puri, P., Höllwarth, M.E. (eds) Pediatric Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-81488-5_49
Download citation
DOI: https://doi.org/10.1007/978-3-030-81488-5_49
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-81487-8
Online ISBN: 978-3-030-81488-5
eBook Packages: MedicineMedicine (R0)